What is Gilead Sciences Inc's current stock price?

View Gilead Sciences Inc (GILD)'s real-time stock price, AI-powered analysis, and key financial metrics on Helm Terminal.

Is GILD a good stock to buy?

GILD analysis includes AI-driven insights covering fundamentals, analyst consensus, and market sentiment. Visit Helm Terminal for the full breakdown.

What is Gilead Sciences Inc's market cap?

Get Gilead Sciences Inc's current market capitalization, P/E ratio, and other key financial metrics with Helm Terminal's free stock analysis tool.

Where can I get free stock analysis for GILD?

Helm Terminal offers free AI-powered stock analysis for GILD, including financial summaries, key metrics, and market insights at helmterminal.dev/analyze/GILD.

GILD Stock Analysis — Helm Terminal

← Back to search

GILDBullish

Gilead Sciences Inc

Helm AI

Gilead Sciences (GILD) is poised for growth, reflected in its impressive EPS growth of 1903.07% year-over-year, and a solid current price of $141.54, which is only 10% below its 52-week high of $157.29. The company's recent acquisition of Tubulis for $5B signals a strategic shift to enhance its cancer drug pipeline, potentially driving future revenue growth beyond its current 2.40% year-over-year revenue increase.

Market Cap

$175.71B

Current Price

$141.54

+1.97%vs previous close

P/E (TTM)

20.58

EPS Growth YoY

1903.07%

Dividend Yield

2.32%

ROE (TTM)

41.02%

Recommendation

Investors should consider a bullish position on Gilead Sciences, given its strategic acquisitions and high EPS growth potential.

Recent Headlines

Gilead Agrees $5 Billion Tubulis Acquisition To Expand Cancer Drug Pipeline

2026-04-08

Gilead Sciences' Tubulis Buy Underscores Shift Beyond HIV, Oppenheimer Says

2026-04-08

Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?

2026-04-08

Gilead Advances But Underperforms Market: Key Facts

2026-04-08